Skip to content

Quick Start Glucose Item #5A15

by Em Diagnostic Systems, Inc. 510(k)

Active United States

510(k) K912808

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK912808 Date30 Jul 1991ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

Full name
Abbott Quick Start Glucose (Glue) Item# 5A15
510(k) Number
FDA Product Code
CFR
Device Class
Class II
Regulation
21 CFR Part 862.1345
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 20 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Quick Start Glucose Item #5A15 is a hexokinase-based glucose test system designed for in vitro diagnostic use. It measures glucose levels in blood samples, facilitating clinical chemistry assessments. The device operates by catalyzing the phosphorylation of glucose to glucose-6-phosphate, enabling quantitative measurement of blood glucose concentrations.

This item is supplied as a single-use reagent kit for laboratory use, requiring no additional sterilization. It is classified under CFR 862.1345 and has been cleared by the FDA under 510(k) K912808. The device is intended for use in clinical chemistry settings and must be stored according to manufacturer instructions to maintain stability and accuracy. No MRI safety information is specified.

Other devices from Em Diagnostic Systems, Inc.

See all devices from Em Diagnostic Systems, Inc. →

Questions

AI-generated answers, 20 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Abbott Quick Start Glucose (GLUE) Item #5A15, and where would it typically be used?

    The Abbott Quick Start Glucose (GLUE) Item #5A15 is a hexokinase-based glucose test system designed for measuring glucose levels in blood samples. It is specifically intended for in vitro diagnostic use in clinical chemistry settings, enabling quantitative measurement of blood glucose concentrations. This makes it suitable for laboratories where precise glucose monitoring is required for clinical assessments.

  • Is this device single-use or reusable, and does it require additional sterilization?

    The Abbott Quick Start Glucose (GLUE) Item #5A15 is supplied as a single-use reagent kit for laboratory use. Since it is designed for one-time use, no additional sterilization is required before use. This ensures consistency and safety in clinical chemistry applications.

  • How should this device be stored to maintain its stability and accuracy?

    The device must be stored according to the manufacturer’s instructions to preserve stability and accuracy. While the exact storage conditions (e.g., temperature, humidity) are not detailed in the provided data, adhering to the manufacturer’s guidelines—likely outlined in the accompanying documentation—will ensure optimal performance for glucose measurement.

  • What regulatory pathway was followed for FDA clearance of this device, and what classification does it fall under?

    The Abbott Quick Start Glucose (GLUE) Item #5A15 was cleared by the FDA under a 510(k) submission (K912808) using the Traditional 510(k) review pathway. It is classified under CFR 862.1345 and is determined to be substantially equivalent to a predicate device. The device falls under the Clinical Chemistry advisory committee (CH) and is categorized as a Class II medical device (as indicated by the OpenFDA data).